2007
DOI: 10.1590/s1516-84842007000200023
|View full text |Cite
|
Sign up to set email alerts
|

Anticorpos antifosfolípides e aterosclerose em pacientes com trombose venosa e/ou arterial

Abstract: ResumoA investigação dos fatores de trombofilia hereditária e adquirida faz parte da abordagem a indivíduos com trombose. Dentre os fatores adquiridos, merecem destaque os anticorpos antifosfolípides e a aterosclerose. Os primeiros constituem um grupo de imunoglobulinas com afinidade por fosfolípides aniônicos ou complexos fosfolípides/proteínas, estando associados ao aparecimento de trombose, plaquetopenia e abortamentos de repetição. A aterosclerose constitui um processo imunológico/inflamatório crônico que … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…It is believed that when free of binding with HDL, they combine with free particles of VLDL ( Very Low Density Lipoprotein ) compounds, which are considered “bad cholesterols”, thus completing their reverse transport and performing a protective function against atherosclerosis [74]. Li and collaborators [75] reported an increase of atherosclerosis cases in an aging population, suggesting that the elevation of atherosclerosis in the elderly may be related to diminished levels of APOs in carrying plasmatic VLDL compounds, thereby inducing greater VLDL deposition in the walls of veins and arteries [76].…”
Section: Discussionmentioning
confidence: 99%
“…It is believed that when free of binding with HDL, they combine with free particles of VLDL ( Very Low Density Lipoprotein ) compounds, which are considered “bad cholesterols”, thus completing their reverse transport and performing a protective function against atherosclerosis [74]. Li and collaborators [75] reported an increase of atherosclerosis cases in an aging population, suggesting that the elevation of atherosclerosis in the elderly may be related to diminished levels of APOs in carrying plasmatic VLDL compounds, thereby inducing greater VLDL deposition in the walls of veins and arteries [76].…”
Section: Discussionmentioning
confidence: 99%